Xilio Therapeutics Director Adds 5,000 Shares in March Transaction
Xilio Therapeutics director Shannon James Samuel purchased 5,000 shares of common stock on March 26, 2026, for a total of $43,949 at a reported price of $8.79 per share. The SEC filing notes transaction prices ranged from $8.6758 to $9.2499. After the purchase, Samuel directly owns 10,000 shares. The transaction occurs while XLO trades at $8.23 and…